These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
    Author: Doongaji DR, Satoskar RS, Sheth AS, Apte JS, Desai AB, Shah BR.
    Journal: J Postgrad Med; 1989 Jan; 35(1):3-8. PubMed ID: 2685263.
    Abstract:
    Twenty-nine acute schizophrenic patients were treated under double-blind conditions for six weeks with either centbutindole in a dose range of 3 mg/day to 4.5 mg/day or trifluoperazine in the dose range of 15 mg/day to 22.5 mg/day. Both drugs produced a significant improvement in initial psychopathology. No significant differences were demonstrated between the two treatment conditions.
    [Abstract] [Full Text] [Related] [New Search]